None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Relias, LLC and National Council for Mental Wellbeing guarantee this educational conference is free from bias.
With the continued legalization of marijuana across the United States, clinicians must consider the appropriateness of individuals using cannabis while in treatment for substance use disorder. This presentation will explore the latest trends and data that treatment organizations can consider when updating their clinical guidelines.
Analyze the latest data related to the use of cannabis while in treatment for substance use disorder.
Explore best practices for working with individuals who wish to continue using cannabis.
Examine the expected trends in treatment guidelines for clinicians.